Skip to main content

Peer Review reports

From: Response to olaparib in metastatic castration-resistant prostate cancer with germline BRCA2 mutation: a case report

Original Submission
12 Apr 2018 Submitted Original manuscript
28 May 2018 Reviewed Reviewer Report - Emmanuel S. Antonarakis
24 Jun 2018 Reviewed Reviewer Report - Harry Ostrer
7 Aug 2018 Author responded Author comments - yi ma
Resubmission - Version 2
7 Aug 2018 Submitted Manuscript version 2
26 Sep 2018 Reviewed Reviewer Report - Emmanuel S. Antonarakis
27 Sep 2018 Author responded Author comments - yi ma
Resubmission - Version 3
27 Sep 2018 Submitted Manuscript version 3
29 Sep 2018 Author responded Author comments - yi ma
Resubmission - Version 4
29 Sep 2018 Submitted Manuscript version 4
Publishing
2 Oct 2018 Editorially accepted
17 Oct 2018 Article published 10.1186/s12881-018-0703-9

You can find further information about peer review here.

Back to article page